LFR: Glucose Dehydrogenase, Glucose

Product code LFR, “Glucose Dehydrogenase, Glucose” in FDA's classification database, is a Class II device type under 21 CFR 862.1345 (glucose test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 73 clearances under LFR, 26 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LFR
Regulation
21 CFR 862.1345
Class
II
Panel
Clinical Chemistry
Clearances
73
Most recent
Sep 17, 2015
Third-party review
Eligible
Implant
No

What it covers

A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

The identification in 21 CFR 862.1345, glucose test system. FDA gives LFR no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K152328FreeStyle InsuLinx Blood Glucose Monotioring SystemAbott LaboratoriesSep 17, 2015Special
K142089ACCU-CHEK AVIVA EXPERT SYSTEMRoche Diagnostics CorporationDec 17, 2014Traditional
K133537EGV1.1 SELF MONITORING BLOOD GLUCOSE SYSTEM AND EGV1.1 PRO MONITORING BLOOD GLUCOSE SYSTEMEps Bio Technology Corp.Apr 28, 2014Special
K131727CERA-CHEK 1070 BLOOD GLUCOSE MONITORING SYSTEMCeragem Medisys, Inc.Feb 28, 2014Traditional
K131366ACCU-CHEK AVIVA EXPERT BLOOD GLUCOSE MONITORING SYSTEMRoche Diagnostics Operations, Inc.Oct 11, 2013Traditional
K122688NOVA MAX MINI BLOOD GLUCOSE AND B-KETONE MONITORNova Biomedical CorporationApr 4, 2013Traditional
K121433GOODLIFE CS-200 (SINGLE PATIENT USE), CS-200 PROFESSIONAL (MULTIPLE PATIENT USE) BLOOD GLUCOSE MONITORING SYSTEMSHmd Biomedical, Inc.Feb 14, 2013Traditional
K122435NOVA ONE BLOOD GLUCOSE MONITORNova Biomedical CorporationDec 20, 2012Traditional
K113314PRECICHEK NS-101 POCT PROFESSIONAL BLOOD GLUCOSE MONITORING SYSTEMHmd Biomedical, Inc.Nov 9, 2012Traditional
K121224GENESIS HEALTH TECHNOLOGIES BLOOD GLUCOSE MONITORING SYSTEMTaidoc Technology CorporationSep 19, 2012Special
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 73 with a free account)

Clearances by year

26 LFR 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2015130
20143161
20133212
201213152
20116296

Who submits

13 applicants cleared a LFR device since 2011. 50% of the clearances went to applicants in Taiwan, then United States (42%), Switzerland (4%) and South Korea (4%). By type: Traditional 65% and Special 35%.

ApplicantClearances since 2011
Eps Bio Technology Corp.6
Taidoc Technology Corporation4
Hmd Biomedical, Inc.3
Bayer Healthcare2
Bayer Healthcare, LLC2
Nova Biomedical Corporation2
Abbott Laboratories1
Abott Laboratories1

How FDA classifies it

Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

From 21 CFR 862.1345. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 862.1345 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LFR clearances declared.

Ask about LFR

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LFR

What is FDA product code LFR?

Product code LFR, “Glucose Dehydrogenase, Glucose” in FDA's classification database, is a Class II device type under 21 CFR 862.1345 (glucose test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 73 clearances under LFR, 26 of them since 2011.

How many 510(k) clearances are there under LFR?

FDA’s 510(k) database listed 73 clearances under LFR as of Oct 29, 2026, 26 of them decided since 2011; the most recent decision was Sep 17, 2015. The Predicate Finder searches the live database.

Which companies have the most LFR clearances?

Since 2011: Eps Bio Technology Corp. (6), Taidoc Technology Corporation (4), Hmd Biomedical, Inc. (3), Bayer Healthcare (2) and Bayer Healthcare, LLC (2). 13 applicants have cleared a LFR device in that time.

Sources

  1. FDA product classification: LFR · Product Classification database
  2. 21 CFR 862.1345: Glucose test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LFR · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LFRGet an email when FDA clears, recalls or publishes guidance for LFR devices.

Know what FDA already cleared.